US 10463674
Process for manufacturing sterile ophthalmic pharmaceutical suspensions
granted A61KA61K31/542A61K47/02
Quick answer
US patent 10463674 (Process for manufacturing sterile ophthalmic pharmaceutical suspensions) held by SENTISS PHARMA PRIVATE LIMITED expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SENTISS PHARMA PRIVATE LIMITED
- Grant date
- Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/542, A61K47/02, A61K47/26, A61K47/32